临床诊断与治疗的新工具——可变淋巴细胞受体

doi:10.3724/SP.J.1005.2013.00055

遗传 ›› 2013, Vol. 35 ›› Issue (1): 55-61.doi: 10.3724/SP.J.1005.2013.00055

临床诊断与治疗的新工具——可变淋巴细胞受体

于涛^1,2, 韩英伦^1,2, 肖蓉^1,2, 刘欣², 李庆伟^1,2

1. 辽宁师范大学生命科学学院, 大连116081 2. 辽宁师范大学海洋生物功能基因及蛋白质组学研究所, 大连 116081

收稿日期:2012-08-07 修回日期:2012-11-09 出版日期:2013-01-20 发布日期:2013-01-25
通讯作者: 李庆伟 E-mail:liqw@263.net
基金资助:
国家自然科学基金项目(编号：31071991)和辽宁省教育厅科研项目(编号：LT2010056)资助

Variable lymphocyte receptors: the novel tool for clinical diagnosis and therapy

YU Tao^1,2, HAN Ying-Lun^1,2, XIAO Rong^1,2, LIU Xin², LI Qing-Wei^1,2

1. College of Life Sciences, Liaoning Normal University, Dalian 116081, China 2. Institute of Marine Genomics & Proteomics, Liaoning Normal University, Dalian 116081, China

Received:2012-08-07 Revised:2012-11-09 Online:2013-01-20 Published:2013-01-25

摘要/Abstract

摘要： 单克隆抗体(Monoclonal antibody, mAb)在癌症以及自身免疫等疾病的诊断与治疗中得到广泛应用, 并且取得了重大进展。当今应用于临床的单克隆抗体是在免疫球蛋白的基础上进行改造研发而得。然而近期发现的无颌类脊椎动物的特异性抗原受体—可变淋巴细胞受体(Variable lymphocyte receptor, VLR), 为抗体类试剂或药物的研发提供了新的视角。与免疫球蛋白(Immunoglobulins, Ig)相比, VLR与抗原结合的特异性、亲和力及稳定性都优于Ig类抗体, 并且抗原特异性单克隆VLR的制备技术日趋成熟。因此, VLR在临床诊断和治疗中具有更高的应用价值, 并可能成为新一代的抗体药物。文章就VLR的基本特征、制备方法及其应用前景进行综述, 为实现VLR在临床诊断与治疗等领域中的应用提供有益参考。

关键词: 可变淋巴细胞受体, 单克隆抗体药物, 临床诊断, 工程蛋白支架

Abstract: Monoclonal antibodies, which are widely applied to the diagnosis and therapy of cancers as well as autoimmune diseases, have been made significant progresses. Currently, the monoclonal antibodies for clinical applications are mostly based on the modified immunoglobulins. However, the variable lymphocyte receptors (VLRs), which are recently discovered as specific antigen receptors of jawless vertebrates, provide a new perspective for the development of antibody reagents and drugs. Compared with immunoglobulins, the antigen-binding specificity, affinity and stability of VLRs-based antibodies are better. In addition, the production technology of antigen-specific monoclonal VLRs has become more and more mature. Therefore, the VLRs have a higher clinical value and may become the next-generation antibody drug. This review focuses on the basic feature, production method and application prospect of VLRs, which provides valuable clues for the applications of VLRs in the field of clinical diagnosis and therapy.

Key words: variable lymphocyte receptor, monoclonal antibody drug, clinical diagnosis, engineered protein scaffold

于涛，韩英伦，肖蓉，刘欣，李庆伟. 临床诊断与治疗的新工具——可变淋巴细胞受体[J]. 遗传, 2013, 35(1): 55-61.

YU Tao HAN Ying-Lun XIAO Rong LIU Xin LI Qing-Wei. Variable lymphocyte receptors: the novel tool for clinical diagnosis and therapy[J]. HEREDITAS, 2013, 35(1): 55-61.

参考文献

[1] Scott AM, Wolchok JD, Old LJ. Antibody therapy of cancer. Nat Rev Cancer, 2012, 12(4): 278-287.
[2] Weiner LM, Murray JC, Shuptrine CW. Antibody-based immunotherapy of cancer. Cell, 2012, 148(6): 1081-1084.
[3] Ordás I, Mould DR, Feagan BG, Sandborn WJ. Anti-TNF monoclonal antibodies in inflammatory bowel disease: pharmacokinetics-based dosing paradigms. Clin Pharmacol Ther, 2012, 91(4): 635 -646.
[4] Chugh PK. Lupus: novel therapies in clinical development. Eur J Intern Med, 2012, 23 (3): 212-218.
[5] Wurch T, Lowe P, Caussanel V, Bes C, Beck A, Corvaia N. Development of novel protein scaffolds as alternatives to whole antibodies for imaging and therapy: status on dis-covery research and clinical validation. Curr Pharm Biotechno, 2008, 9(6): 502-509.
[6] Skerra A. Alternative non-antibody scaffolds for molecular recognition. Curr Opin Biotech, 2007, 18(4): 295-304.
[7] Pancer Z, Amemiya CT, Ehrhardt GRA, Ceitlin J, Gartland GL, Cooper MD. Somatic diversification of variable lym-phocyte receptors in the agnathan sea lamprey. Nature, 2004, 430(6996): 174- 180.
[8] Alder MN, Herrin BR, Sadlonova A, Stockard CR, Grizzle WE, Gartland LA, Gartland GL, Boydston JA, Turnbough CL Jr, Cooper MD. Antibody responses of variable lym-phocyte receptors in the lamprey. Nat Immunol, 2008, 9(3): 319-327.
[9] Herrin BR, Alder MN, Roux KH, Sina C, Ehrhardt GR, Boydston JA, Turnbough CL Jr, Cooper MD. Structure and specificity of lamprey monoclonal antibodies. Proc Natl Acad Sci USA, 2008, 105 (6): 2040-2045.
[10] Pancer Z, Saha NR, Kasamatsu J, Suzuki T, Amemiya CT, Kasahara M, Cooper MD. Variable lymphocyte receptors in hagfish. Proc Natl Acad Sci USA, 2005, 102(26): 9224-9229.
[11] Kasamatsu J, Sutoh Y, Fugo K, Otsuka N, Iwabuchi K, Kasahara M. Identification of a third variable lymphocyte receptor in the lamprey. Proc Natl Acad Sci USA, 2010, 107(32): 14304- 14308.
[12] Rogozin IB, Iyer LM, Liang L, Glazko GV, Liston VG, Pavlov YI, Aravind L, Pancer Z. Evolution and diversifi-cation of lamprey antigen receptors: evidence for involvement of an AID-APOBEC family cytosine deaminase. Nat Immunol, 2007, 8(6): 647-656.
[13] Nagawa F, Kishishita N, Shimizu K, Hirose S, Miyoshi M, Nezu J, Nishimura T, Nishizumi H, Takahashi Y, Hashimoto SI, Takeuchi M, Miyajima A, Takemori T, Otsuka AJ, Sakano H. Antigen-receptor genes of the agnathan lamprey are assembled by a process involving copy choice. Nat Immunol, 2007, 8(2): 206-213.
[14] Alder MN, Rogozin IB, Iyer LM, Glazko GV, Cooper MD, Pancer Z. Diversity and function of adaptive immune receptors in a jawless vertebrate. Science, 2005, 310(5756): 1970-1973.
[15] Han BW, Herrin BR, Cooper MD, Wilson IA. Antigen recognition by variable lymphocyte receptors. Science, 2008, 321(5897): 1834-1837.
[16] Boehm T, McCurley N, Sutoh Y, Schorpp M, Kasahara M, Cooper MD. VLR-based adaptive immunity. Annu Rev Immunol, 2012, 30(1): 203-220.
[17] Flajnik MF, Kasahara M. Origin and evolution of the adaptive immune system: genetic events and selective pressures. Nat Rev Genet, 2010, 11(1): 47-59.
[18] Kim HM, Oh SC, Lim KJ, Kasamatsu J, Heo JY, Park BS, Lee H, Yoo OJ, Kasahara M, Lee JO. Structural diversity of the hagfish variable lymphocyte receptors. J Biol Chem, 2007, 282(9): 6726-6732.
[19] Velikovsky CA, Deng L, Tasumi S, Iyer LM, Kerzic MC, Aravind L, Pancer Z, Mariuzza RA. Structure of a lamprey variable lymphocyte receptor in complex with a protein antigen. Nat Struct Mol Biol, 2009, 16(7): 725-730.
[20] Tasumi S, Velikovsky CA, Xu G, Gai SA, Wittrup KD, Flajnik MF, Mariuzza RA, Pancer Z. High- affinity lamprey VLRA and VLRB monoclonal antibodies. Proc Natl Acad Sci USA, 2009, 106(31): 12891-12896.
[21] Deng L, Velikovsky CA, Xu G, Iyer LM, Tasumi S, Kerzic MC, Flajnik MF, Aravind L, Pancer Z, Mariuzza RA. A structural basis for antigen recognition by the T cell-like lymphocytes of sea lamprey. Proc Natl Acad Sci USA, 2010, 107(30): 13408-13413.
[22] Padlan EA, Silverton EW, Sheriff S, Cohen GH, Smith-Gill SJ, Davies DR. Structure of an antibody-antigen complex: crystal structure of the HyHEL-10 Fab-lysozyme complex. Proc Natl Acad Sci USA, 1989, 86(15): 5938-5942.
[23] Wezner-Ptasińska M, Krowarsch D, Otlewski J. Design and characteristics of a stable protein scaffold for specific binding based on variable lymphocyte receptor sequences. Biochim Biophys Acta, 2011, 1814(9): 1140-1145.
[24] Chao GE, Lau WL, Hackel BJ, Sazinsky SL, Lippow SM, Wittrup KD. Isolating and engineering human antibodies using yeast surface display. Nat Protoc, 2006, 1(2): 755-768.
[25] Gai SA, Wittrup KD. Yeast surface display for protein engineering and characterization. Curr Opin Struct Biol, 2007, 17(4): 467-473.
[26] Xu G, Tasumi S, Pancer Z. Yeast surface display of lamprey variable lymphocyte receptors. Methods Mol Biol, 2011, 748: 21-33.
[27] Marks JD, Bradbury A. Selection of human antibodies from phage display libraries. Methods Mol Biol, 2004, 248: 161-176.
[28] Lee SC, Park K, Han J, Lee JJ, Kim HJ, Hong S, Heu W, Kim YJ, Ha JS, Lee SG, Cheong HK, Jeon YH, Kim D, Kim HS. Design of a binding scaffold based on variable lymphocyte receptors of jawless vertebrates by module engi-neering. Proc Natl Acad Sci USA, 2012, 109(9): 3299-3304.
[29] Nuttall SD, Wilkins ML, Streltsov VA, Pontes-Braz L, Dolezal O, Tran H, Liu CQ. Isolation, kinetic analysis, and structural characterization of an antibody targeting the Bacillus anthracis major spore surface protein BclA. Proteins, 2011, 79(4): 1306-1317.
[30] Kirchdoerfer RN, Herrin BR, Han BW, Turnbough CL Jr, Cooper MD, Wilson IA. Variable lymphocyte receptor recognition of the immunodominant glycoprotein of Bacillus anthracis spores. Structure, 2012, 20(3): 479-486.
[31] Sarkar S, Tang XL, Das D, Spencer JS, Lowary TL, Suresh MR. A bispecific antibody based assay shows po-tential for detecting tuberculosis in resource constrained laboratory settings. PLoS ONE, 2012, 7(2): e32340.
[32] Kontermann R. Dual targeting strategies with bispecific antibodies. MAbs, 2012, 4(2): [Epub ahead of print]. (未出版刊物)
[33] Yu CL, Ali S, St-Germain J, Liu YL, Yu XC, Jaye DL, Moran MF, Cooper MD, Ehrhardt GRA. Purification and identification of cell surface antigens using lamprey monoclonal antibodies. J Immunol Methods, 2012, 386(1-2): 43-49.
[34] Hong X, Ma MZ, Gildersleeve JC, Chowdhury S, Barchi JJ Jr, Mariuzza RA, Murphy MB, Mao L, Pancer Z. Sugar-binding proteins from fish: selection of high affinity "Lambodies" that recognize biomedically relevant glycans. ACS Chem Biol, 2012, [Epub ahead of print]. (未出版刊物)
[35] Gebauer M, Skerra A. Engineered protein scaffolds as next-generation antibody therapeutics. Curr Opin Chem Biol, 2009, 13(3): 245-255.

编辑推荐

Metrics

www.chinagene.cn
备案号：京ICP备09063187号-4
总访问:,今日访问:,当前在线:

临床诊断与治疗的新工具——可变淋巴细胞受体

Variable lymphocyte receptors: the novel tool for clinical diagnosis and therapy

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 4

编辑推荐

Metrics

[1]	邵谦之, 姜毅, 吴金雨. 全基因组测序及其在遗传性疾病研究及诊断中的应用[J]. 遗传, 2014, 36(11): 1087-1098.
[2]	吴芬芳，马宁，陈立勇，苏鹏，李庆伟. 日本七鳃鳗(Lampetra japonica)VLRB的克隆表达及单克隆抗体制备[J]. 遗传, 2012, 34(4): 465-471.
[3]	张鑫，李敏，张学军. 全基因组外显子测序及其应用[J]. 遗传, 2011, 33(8): 847-856.
[4]	吴晓静，任建功，刘永江，刘军连，汪建军，谭萍萍，冉多良，马润林. 尖锐湿疣样本中HPV病毒的分子检测[J]. 遗传, 2005, 27(5): 699-704.